The most frequently reported drug-related TEAEs in ≥2% of patients on placebo were dizziness and headache, whereas in both Risperidone ISM® groups (75 and 100 mg) were blood prolactin increase, hyperprolactinaemia, akathisia, and headache (Table 3). The gene discussed is PRL; the disease is hyperpituitarism.